NCT00564148View on ClinicalTrials.gov

Intravitreal Avastin in Proliferative Retinopathies

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Retinal Neovascularization
Interventions
DRUG

Avastin

2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively

Trial Locations (1)

700377

Ochiul Diabetic, Iași

All Listed Sponsors
lead

Ophthalmological Association Edelweiss

OTHER

NCT00564148 - Intravitreal Avastin in Proliferative Retinopathies | Biotech Hunter | Biotech Hunter